Cannabis PolicyNews Briefs

Trump Signs Executive Order Supporting State-Run Psychedelics Programs

President Donald Trump (R) last week signed an executive order to support psychedelics as a potential treatment for some mental health conditions. The order directs $50 million in federal funds to make the drugs more accessible via state-run programs, and requires the Food and Drug Administration (FDA) to expedite a review of some psychedelic drugs, including psilocybin and ibogaine.  The order includes a provision that would require “timely rescheduling” of any current […]